Bausch + Lomb Receives FDA Approval of the Trulign Toric PCIOL
The Trulign Toric PCIOL (Bausch + Lomb), the first
toric IOL that provides astigmatic correction and
improved uncorrected near, intermediate, and distance
vision, has received FDA approval.
The FDA-approved indication of the Trulign is for
“primary implantation in the capsular bag of the eye
for the visual correct...